Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company.

Dr. Shepard’s experience in multiple therapeutic areas includes diverse disciplines of medical affairs and product commercialization. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).  In 2016-17, he was President of the Medical Affairs Professional Society (MAPS).

Before his pharmaceutical career, Dr. Shepard completed his hematology and oncology fellowships at the University of Chicago and then served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation.  He has more than 50 medical publications in journals and books.

Sabina began her Health Economics and Outcomes Research career with Pfizer in 1997 where she supported several important brands – Viagra, Celebrex, Geodon and the Anti-Infective Portfolio.  She supported both the US and Global markets and has extensive launch experience.  Sabina also spent 3 years in Europe supporting Europe and Canada.  There she developed a deep knowledge of the HTA landscape and the important role health economics plays in access and reimbursement. 

In 2008, Sabina was asked to create the Health Economics and Outcomes Research Group for Pfizer Animal Health.  There she built a team who supported the US and Global business and became an expert in leveraging HEOR data to drive sales.  HEOR has been adopted by other Animal Health companies and has become an important business driver for these companies.

In 2016 Sabina joined Genentech/Roche where she led the development and implementation of a Patient Reported Outcomes strategy for a broad portfolio of products.  In 2018, Sabina joined Abbvie where she leads the HEOR Oncology team. The team supports both the commercial business and the pipeline providing real world evidence and economic analyses and models for the portfolio.

Sabina holds a Master of Arts degree in Political Science from the University of London, a Master’s degree in Public Health (MPH) from City University of New York and a Bachelor of Arts in History from Lake Forest College.

Dr Aliki Taylor works at AstraZeneca as Senior Director and Head of Real World Evidence (Oncology) in the Oncology Business Unit. She has unique experience with leadership roles in the pharmaceutical industry (12 years), academia (7 years), and NHS (8 years) having worked as a NHS physician and Public Health doctor. Her passion is to help patients with cancer globally through impactful scientific studies, building and leading highly performing teams and creating collaborative scientific networks in medical evidence generation. In her current role she is accountable for driving scientific aspects of real world evidence and outcomes research for oncology. She has multiple congress presentations and manuscripts published in peer reviewed journals and recognises the significant value of working with patient groups and expert clinicians to better gain their input into study design, execution, dissemination and communication of patient centric study results.

Enkeleida has a dozen of years’ experience in the pharmaceutical industry in various roles ranging from Patient-reported Outcomes, Health Outcomes, market access and Real world evidence. At the start of her career as consumer psychologist she has worked in various projects conducting research focused in understanding human behavior.

Jacek Nowak is Amgen’s Executive Medical Director for European Mid-Size Markets. Jacek has been active as biopharmaceutical industry leader for over 25 years.

Prior to joining Amgen in 2003, Jacek served as Medical Director for Central Europe with Wyeth. He had also held a role of Marketing and Sales Manager with Cilag and prior to that he worked as a medical doctor at the Cardiology and Intensive Care Unit at the University Hospital of the Silesian School of Medicine in Katowice, Poland.

Jacek holds a degree of medical doctor and earned his doctorate on research work on leptin receptor polymorphism. Jacek holds a Diploma in Pharmaceutical Medicine from the Royal College of Physicians in London. Jacek’s expertise pertains to area of organ transplantation, oncology, cardiology and metabolic disorders.

Peter Shaw is Global Vice President of Medical Affairs and Chief Medical Officer at Bioventus having spent the previous three years as Senior Medical Director in Medical Affairs at Ferring Pharmaceuticals where he was responsible for all US Orthopaedic and Specialty Products. Prior to that Peter was Chief Medical Officer at Emisphere Technologies and Q-Pharma. He received his medical training at the University of London, Charing Cross & Westminster Hospital Medical School and postgraduate medical education in Orthopaedics and General Surgery as well as OBGYN, General Medicine, Cardiology and Cardiopulmonary Transplant Medicine. He practiced in the United Kingdom for 23 years before entering the pharmaceutical industry and moving to the USA in 2006. While in clinical practice, Peter was also post-graduate tutor in primary care and attending physician to a professional rugby club for 13 years.

Manager of Research and Development in The Association of the Pharmaceutical Industry in Norway – LMI.
Monica has long experience from research and development within the pharmaceutical industry, and as a background as a molecular biologist she closely follows the data driven development of the treatment options of the future.

MASSIMO G. BARBERIO is actually GovernmentAffairs, Policy& Health Economics Director Italy in GE Healthcare Italy He started his career working in the commercial department of a medium size pharmaceutical company, dealing with diagnostic hospital pharma products. After several assignments in marketing field for several large pharmaceutical companies, in 2007 he joined GE Healthcare, as South Europe Marketing Director for the Pharmaceutical Division.Since 2011Massimocovers the role of GovernmentAffairs, Policy& Health Economics Director Italy in GE HealthcareMedical Systems, dealing with the technological and pharmaceutical product portfolio and managing the Market Access activities in General Electric Healthcare. In his activity he managesthe Company official relationships with Institutions like Government and Parliament members, Health and University Ministry, Government Agencies, Professional Societies. He is in the staff of the Southern Europe President of GE Healthcare. He is member of the Italian Society of Clinical Radiology since 1995, and he is also part of the Italian Association of Nuclear Medicine, Massimo obtained also several academic assignments: appointed as Visiting Professor at the Radiology School of the Medicine Faculty at the Milano Bicocca University and as lecturer at the MBA courses at L. Bocconi University and Management School in Milan and at LUISS University in Rome, he is actually Visiting Professor at the Research Centre for study on Healthcare Management at the LIUC University of Castellanza and member of the steering committee and Professor atthe School of Finance and Management at Universitàdel Piemonte Orientale di Novara. He is author of several clinical and pharmacoeconomy papers published on some national and international peer reviewed journals, as the Italian Journal of Radiology and the California Management Review. He has a master’sdegree in Biology and a Master in Strategic Marketingandalso MasterinHealthcareEconomy and Management Born in Milan 60years ago,Massimo is married with Angela and they have one son, Daniele, 31years old and one daughter, Martina 27years old. He enjoys spending his time with his family and reading, and after a brilliant career as Italian major league Handball referee, actually his sport activity is limited todiscussions with friends on soccer games seen on TV.

Member of national and international professional and non professional  diabetes associations,

Former positions: Chair of IDF Europe (1997- 2003), IDF Vice-president (2003-2009) , Chairman of the IDF Science TF (2009-2012). Founder of the Members of the European Parliament Diabetes Working Group. Member of the Faculty of Medicine and Chair of the Schools of Podology and of Nursing Sciences of the University of Perugia (I); Chair of the Umbria Regional Diabetes Reference Centre; Co-director of the WHO Collaborating Centre for Diabetes Care Improvement. Director of Research and Education at Dasman Institute for Diabetes Research (Kuwait, 2007-2009).

At present: Chair of the EUBIROD Network. , President of the HUB for International health ReSearch-HIRS. Co-chair of the International ICHOM Working Group for Diabetes Standard Set. Member of the European Union Diabetes Forum (EUDF) Working Group on Data and Registries. Chair of the Working Group on Value Based Health Care-VBHC of the Project on clinical and social frailties within the Italian Health Care System before, during and after Covid-19

Main areas of diabetes research: pathophysiology; new drugs; advanced systems for insulin delivery; complications; pregnancy; metabolic monitoring; epidemiology, diabetes registries; ethics. Member of EU projects EURODIABETA; DIABCARD 1-4; DIABCARE 1-3; MFIT; DIABSTYLE 1-2; ADICOL, IMMIDIAB, PARENT, CHRODIS, BRIDGE Health and Project leader of B.I.R.O. and EUBIROD

Erik Briers received a Doctorate of Science in Chemistry from KU Leuven. He was a Guest lecturer on principles of immunology and drug design in the treatment of cancer at the University of Leuven.
Erik has been active since 2012 with the European Cancer Patient Coalition as Executive Director and since 2002 with Europa Uomo – a
Prostate Cancer focused patient organisation. For many years Erik is involved as a patient advocate in working with the EMA (PCWP, SAG and CAT). Erik is also Founder and CEO of Beta Ventures, whose main activities are publishing and editing Focus Diagnostica (a magazine on in vitro diagnostics) & organising continued education for clinical pathologists.

Carine Odouard is the Global Business Development Director and Head of RWE at Carenity, The Patient Insights’ Company (EvidentIQ Group).

Before joining Carenity, Carine spent 15 years working in the Pharma Industry. She began her career in Marketing working for AstraZeneca and Baxter in various therapeutics areas. She then held responsibilities in commercial strategy and market access to finally join Roche as Commercial Head within the Market Access Team focusing her efforts to ensure a better access to innovation for patients. Driven by the desire to make patient-centricity come true she joined Carenity to facilitate real-life patients' studies.

Dr. Ignacio H. Medrano is a Consultant Neurologist with training in
Healthcare Management and experience in Clinical research
strategies (formerly responsible for +500 researchers).
A Singularity University graduate, he is a founder at Mendelian in
the UK (AI for diagnose of rare diseases) and at Savana (Real
World Evidence using AI on Electronic Medical Records).
In 2021 Forbes praised Dr Ignacio H. Medrano, including
him in the list of the 100 most creative Spaniards in the business
world.
From the European Commision to the British Royal Academy of
Science, Ignacio is a well-known international speaker.

Jeff has been involved in biomedical informatics for more than two decades and has a passion for helping people gain value from large volumes of data. He has been solving Big Data problems with artificial intelligence even before Big Data got its name. Jeff was the founder of a successful biomedical information visualization company and now, at Quertle, he is using artificial intelligence, quantum logic, visual analytics, and other methods to provide effective discovery from biomedical information.

Jeff received his Ph.D. in Molecular Biophysics and Biochemistry from Yale. He has received several honors for his biomedical Big Data analytics work, including an R&D100 award.

Chahrazed has worked for more than 8 years in a software company helping industry customers - mainly life sciences companies - to get access to scientific literature. She has recently joined Karger publishers as a Business Development Manager Europe to pursue this mission and to contribute to the core mission Karger Publishers has in connecting and advancing health sciences.

Evi is a Technical Lead at Google Cloud, specializing in Life Sciences Research & Healthcare Solutions. Technology for health is her sweet spot. She is an electrical & computer engineer, turned biomedical researcher, turned technologist. She enjoys designing for scale and inspiring change. At Google Cloud, her focus is on solving real-world problems with technology.

Dr Rujuta Sanap is a healthcare professional specializing in Health Sciences, Public Health Management, Health policy and Health Economics. At Google Cloud, she works on solving real-world problems with data-powered innovation and technology as a Customer Engineer focussed on Global Public Sector, Healthcare and Life Sciences. Before Google, she worked as a senior consultant at IQVIA and gained 5+ years of experience in social media analytics, HEOR, research and consulting across healthcare and pharmaceuticals markets globally. Her academic research has been focused on social health insurance, universal healthcare, health impact of trade policies and behavioral economics. She holds an MSc in International Health Policy and Health Economics from the London School of Economics and Political Science, an MBA in Health Management from Institute of Health Management Research and a baccalaureate in Health Sciences and Dental Surgery.